The Scientist Logo_white
eBOOK

A Guide for Optimizing Arrayed CRISPR Screens

Using sgRNA libraries for target identification and validation during drug discovery

 


synthego-logo-black-w-background (2)

473x300 Laptop on F6F6F6

Loss-of-function (LOF) screens measure the phenotypic effects of gene disruptions, which helps researchers identify and validate gene targets for drug discovery. CRISPR-Cas9 technology has enabled great advances in LOF screening. While researchers typically use pooled CRISPR screens to assess fitness phenotypes, arrayed screens are amenable to a variety of functional assays.

Download this ebook from Synthego to learn more about using arrayed CRISPR screens for target identification and drug discovery validation.
   

The Scientist c/o LabX Media Group
1000 N West Street, Suite 1200, Wilmington, Delaware, United States, 19801
Toll Free: 888.788.0328 | Phone: 705.528.6888
Email: privacy@the-scientist.com

Privacy Policy

© 1986-2022  The Scientist
 
The Scientist Logo_white

The Scientist needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy.